Back to BlackRock, Inc. BlackRock, Inc.

IOVAIOVA
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in IOVANCE BIOTHERAPEUTICS INC

BlackRock, Inc. holds 37M shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), worth $153.7M as of 2026-Q2. The position was increased (+18.9% shares). IOVA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$153.7M

Current Shares

37M

Total Value Change

-$20M

Total Shares Change

+13.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
37M
+18.9%
$153.7M0.0%$4.16
36
2026-Q1
Increased
31.1M
+5.3%
$109.1M0.0%$3.51
32
2025-Q4
Increased
29.5M
+13.7%
$80.6M0.0%$2.73
34
2025-Q3
Increased
26M
+11.7%
$56.3M0.0%$2.17
33
2025-Q2
Decreased
23.2M
-4.4%
$40M0.0%$1.72
0
2025-Q1
Increased
24.3M
+3.6%
$81M0.0%$3.33
31
2024-Q4
First report
23.5M
-
$173.7M0.0%$7.40
0

Other major holders of IOVA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used